← back to search

Stephen M. Massa

San Francisco VA Medical Center · US
Area of research
Cellular and Molecular Neuroscience · Physiology
Research interest
Research interests include Nerve injury and regeneration, Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, and Neuroinflammation and Neurodegeneration Mechanisms.
h-index
47
citations
6,804
works
112
NIH funding
primary concept
email

Recent publications

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Nature Medicine 2024cited by 53position: middledoi
Activity‐dependent dysfunctional gene expression patterns are normalized by <i>in vivo</i> treatment of late‐stage Aβ pathology mice with a TrkB/C small molecule ligand
Alzheimer s & Dementia 2021cited by 0position: middledoi
Nerve Growth Factor Pathobiology During the Progression of Alzheimer’s Disease
Frontiers in Neuroscience 2019cited by 89position: middledoi
P3‐212: A SMALL MOLECULE TRKB/TRKC NEUROTROPHIN RECEPTOR CO‐ACTIVATOR PREVENTS SYNAPTIC IMPAIRMENT IN AN AD MOUSE MODEL
Alzheimer s & Dementia 2019cited by 0position: middledoi
Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP
Nature Communications 2017cited by 131position: middledoi
The Neurotrophic Factor Receptor p75 in the Rat Dorsolateral Striatum Drives Excessive Alcohol Drinking
Journal of Neuroscience 2016cited by 55position: middledoi
The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation
Biological Psychiatry 2015cited by 92position: middledoi
A Small Molecule p75NTR Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression
PLoS ONE 2014cited by 104position: middledoi
Small Molecule p75NTR Ligands Reduce Pathological Phosphorylation and Misfolding of Tau, Inflammatory Changes, Cholinergic Degeneration, and Cognitive Deficits in AβPPL/S Transgenic Mice
Journal of Alzheimer s Disease 2014cited by 100position: middledoi
Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease
Nature Reviews Drug Discovery 2013cited by 307position: lastdoi
A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease
Journal of Neuroscience 2013cited by 147position: middledoi
A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model
Neurobiology of Aging 2013cited by 128position: middledoi
Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury
Journal of Neuroscience 2013cited by 116position: middledoi
A small molecule p75NTR ligand protects neurogenesis after traumatic brain injury
Stem Cells 2013cited by 87position: lastdoi
S4–02–04: Targeting Alzheimer's disease–related mechanisms with p75 ligands
Alzheimer s & Dementia 2013cited by 0position: middledoi
A TrkB Small Molecule Partial Agonist Rescues TrkB Phosphorylation Deficits and Improves Respiratory Function in a Mouse Model of Rett Syndrome
Journal of Neuroscience 2012cited by 151position: middledoi
Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor
Journal of Neuroinflammation 2012cited by 146position: middledoi
PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease
Journal of Huntington s Disease 2012cited by 75position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Frank M. Longo · Stanford University15 papers (2012–2024)Tao Yang · Palo Alto University6 papers (2012–2019)Danielle A. Simmons · Stanford University4 papers (2013–2014) · 3 papers (2013–2014)Juliet K. Knowles · Palo Alto University3 papers (2013–2014)Mehrdad Shamloo · Palo Alto University2 papers (2013–2014)Seok Joon Won · San Francisco VA Medical Center2 papers (2012–2017)Jian Shi · San Francisco VA Health Care System2 papers (2012–2013)Dorit Ron · University of California, San Francisco2 papers (2015–2016)Kevin Tran · The University of Texas MD Anderson Cancer Center2 papers (2019–2021) · 2 papers (2013–2014)Raymond A. Swanson · San Francisco VA Medical Center2 papers (2012–2017)Thuy‐Vi V. Nguyen · Palo Alto University2 papers (2013–2014)Tony Wyss‐Coray · Neurosciences Institute2 papers (2013–2014)Ottavio Arancio · Columbia University2 papers (2013–2013)Vincent Warnault · Pompeu Fabra University2 papers (2015–2016)Khanhky Phamluong · University of California, San Francisco2 papers (2015–2016)Nadège Morisot · Electronic Arts (United States)2 papers (2015–2016)Emmanuel Darcq · Inserm2 papers (2015–2016)Amira Latif‐Hernandez · Palo Alto University2 papers (2019–2021)